hydroquinone has been researched along with decitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, X; Han, Y; Jiang, F; Ling, X; Liu, L; Meng, J; Pan, Z; Yuan, Q; Zhang, H; Zheng, D; Zhong, B; Zhong, Q | 1 |
2 other study(ies) available for hydroquinone and decitabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
PARP-1 inhibits DNMT1-mediated promoter methylation and promotes linc01132 expression in benzene-exposed workers and hydroquinone-induced malignant transformed cells.
Topics: Benzene; Decitabine; DNA; DNA Methylation; Humans; Hydroquinones; Poly(ADP-ribose) Polymerase Inhibitors; Promoter Regions, Genetic; RNA, Long Noncoding | 2023 |